Clinical trial
Study to Evaluate the Safety of a Bivalent Vaccine of New 6:2 Influenza Virus…
NCT00192127 · MedImmune LLC, Industry · Completed
Key facts
| NCT number | NCT00192127 |
|---|---|
| Title | Study to Evaluate the Safety of a Bivalent Vaccine of New 6:2 Influenza Virus Reassortants in Healthy Adults |
| Official title | A Prospective, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety of a Bivalent Vaccine of New 6:2 Influenza Virus Reassortants in Healthy Adults |
| Lead sponsor | MedImmune LLC, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Influenza |
| Intervention type | Biological, Other |
| Interventions | FluMist, Placebo |
| Enrollment | 300 |
| Start date | Aug 1, 2004 |
| Completion | Feb 1, 2005 |
| First posted | Sep 19, 2005 |
| Last update posted | Dec 18, 2007 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: